Intact Therapeutics is a makers of smart gels for local drug delivery for gastrointestinal diseases.
Intact Therapeutics's investors include Y Combinator, National Science Foundation, Newchip Accelerator, Brightstone Venture Capital, Smart Launch Ventures.
Intact Therapeutics is headquartered in Palo Alto, United States.
Intact Therapeutics is a makers of smart gels for local drug delivery for gastrointestinal diseases.
Intact Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Intact Therapeutics — Funding & Investors." VCBacked, November 17, 2021, https://www.vcbacked.co/company/intact-therapeutics. Accessed August 14, 2026.
VCBacked. (2021). Intact Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/intact-therapeutics
{{cite web |title=Intact Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/intact-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated